Inogen (INGN) EBITDA (2013 - 2026)

Inogen (INGN) has 14 years of EBITDA data on file, last reported at -$9.3 million in Q1 2026.

• On a quarterly basis, EBITDA fell 21.94% year-over-year to -$9.3 million in Q1 2026; TTM through Mar 2026 was -$31.9 million, a 5.93% increase from a year earlier, with the FY2025 full-year figure at -$30.2 million, up 28.95% from the prior year.
• EBITDA for Q1 2026 stood at -$9.3 million, roughly flat from -$9.3 million in the prior quarter.
• Over the last five years, EBITDA for INGN reached as high as -$2.9 million in Q2 2022 and fell as low as -$58.5 million in Q4 2022.
• Historically, EBITDA has averaged -$16.3 million across 5 years, with a median of -$10.3 million in 2022.
• Across the five-year window, EBITDA plunged 776.5% in 2022 and surged 83.32% in 2024, its largest moves.
• Year by year, EBITDA stood at -$58.5 million in 2022, then soared by 50.45% to -$29.0 million in 2023, then jumped by 60.71% to -$11.4 million in 2024, then grew by 18.27% to -$9.3 million in 2025, then dropped by 0.32% to -$9.3 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$9.3 million in Q1 2026, -$9.3 million in Q4 2025, and -$7.1 million in Q3 2025.